Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted
The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled.
Subscribe to:
Post Comments
(
Atom
)
No comments